232 related articles for article (PubMed ID: 27508192)
1. c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
Granito A; Guidetti E; Gramantieri L
J Hepatocell Carcinoma; 2015; 2():29-38. PubMed ID: 27508192
[TBL] [Abstract][Full Text] [Related]
2. Role of HGF/MET axis in resistance of lung cancer to contemporary management.
Raghav KP; Gonzalez-Angulo AM; Blumenschein GR
Transl Lung Cancer Res; 2012 Sep; 1(3):179-93. PubMed ID: 25806180
[TBL] [Abstract][Full Text] [Related]
3. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
García-Vilas JA; Medina MÁ
World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
[TBL] [Abstract][Full Text] [Related]
4. Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer.
Miranda O; Farooqui M; Siegfried JM
Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30134579
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment.
Rothenberger NJ; Stabile LP
Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28441771
[TBL] [Abstract][Full Text] [Related]
6. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
Moosavi F; Giovannetti E; Saso L; Firuzi O
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):533-566. PubMed ID: 31512514
[TBL] [Abstract][Full Text] [Related]
7. Understanding c-MET signalling in squamous cell carcinoma of the head & neck.
Szturz P; Raymond E; Abitbol C; Albert S; de Gramont A; Faivre S
Crit Rev Oncol Hematol; 2017 Mar; 111():39-51. PubMed ID: 28259294
[TBL] [Abstract][Full Text] [Related]
8. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
Yang XM; Park M
Lab Invest; 1995 Oct; 73(4):483-91. PubMed ID: 7474919
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.
Hu CT; Wu JR; Cheng CC; Wu WS
Cancers (Basel); 2017 May; 9(6):. PubMed ID: 28587113
[TBL] [Abstract][Full Text] [Related]
10. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.
Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA
J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472
[TBL] [Abstract][Full Text] [Related]
11. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Huang X; Gan G; Wang X; Xu T; Xie W
Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
[TBL] [Abstract][Full Text] [Related]
12. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma.
Wang H; Rao B; Lou J; Li J; Liu Z; Li A; Cui G; Ren Z; Yu Z
Front Cell Dev Biol; 2020; 8():55. PubMed ID: 32117981
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
[TBL] [Abstract][Full Text] [Related]
14. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.
Takayama H; LaRochelle WJ; Sharp R; Otsuka T; Kriebel P; Anver M; Aaronson SA; Merlino G
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):701-6. PubMed ID: 9012848
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase.
Nakanishi K; Fujimoto J; Ueki T; Kishimoto K; Hashimoto-Tamaoki T; Furuyama J; Itoh T; Sasaki Y; Okamoto E
Clin Exp Metastasis; 1999; 17(6):507-14. PubMed ID: 10763917
[TBL] [Abstract][Full Text] [Related]
16. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.
Korhan P; Erdal E; Atabey N
Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462
[TBL] [Abstract][Full Text] [Related]
17. Targeting the MET gene for the treatment of non-small-cell lung cancer.
Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
[TBL] [Abstract][Full Text] [Related]
18. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis.
Rhee H; Kim HY; Choi JH; Woo HG; Yoo JE; Nahm JH; Choi JS; Park YN
Cancer Res; 2018 Apr; 78(7):1619-1631. PubMed ID: 29363547
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells.
Brinkmann V; Foroutan H; Sachs M; Weidner KM; Birchmeier W
J Cell Biol; 1995 Dec; 131(6 Pt 1):1573-86. PubMed ID: 8522613
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
